Comorbidity index for predicting mortality at 6 months after reperfusion therapy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- SCIENTIFIC REPORTS11(1) · 2021
- 피인용
- Web of Science 10Scopus 9
- FWCI (Scopus)
- 0.31
- JCR IF
- JCR 2020 4.38
- ISSN
- 2045-2322
저자
- Nam, Hyo Suk제1저자Department of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Kim, Young DaeDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Yoo, JoonsangDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Park, HyungjongDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Kim, Byung MoonDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea
- Bang, Oh YoungDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Kim, Hyeon ChangDepartment of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea
- Han, EunaCollege of Pharmacy, Yonsei Institute for Pharmaceutical Research, Yonsei University, Incheon, South Korea
- Kim, Dong JoonDepartment of Radiology, Yonsei University College of Medicine, Seoul, Korea
- Heo, JoonyungDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Kim, MinyoungDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Choi, Jin KyoDepartment of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu, Seoul, 03722, Korea
- Lee, Kyung-YulDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea
- Lee, Hye SunDepartment of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea
- Shin, Dong HoonDepartment of Neurology, Gachon University Gil Medical Center, Incheon, Korea
- Choi, Hye-YeonDepartment of Neurology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea
- Sohn, Sung-IlDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea
- Hong, Jeong-HoDepartment of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea
- Lee, Jong YunDepartment of Neurology, National Medical Center, Seoul, Korea
- Baek, Jang-HyunDepartment of Neurology, National Medical Center, Seoul, Korea
- Kim, Gyu SikDepartment of Neurology, National Health Insurance Service Ilsan Hospital, Ilsan, Korea
- Seo, Woo-KeunDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Chung, Jong-WonDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Kim, Seo HyunDepartment of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
- Song, Tae-JinDepartment of Neurology, College of Medicine, Ewha Woman’s University, Seoul, Korea
- Han, Sang WonDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
- Park, Joong HyunDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
- Kim, JinkwonDepartment of Neurology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
- Jung, Yo HanDepartment of Neurology, Gangnam Severance Hospital, Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea
- 조한진Department of Neurology, Pusan National University School of Medicine, Busan, Korea
초록
The eligibility of reperfusion therapy has been expanded to increase the number of patients. However, it remains unclear the reperfusion therapy will be beneficial in stroke patients with various comorbidities. We developed a reperfusion comorbidity index for predicting 6-month mortality in patients with acute stroke receiving reperfusion therapy. The 19 comorbidities included in the Charlson comorbidity index were adopted and modified. We developed a statistical model and it was validated using data from a prospective cohort. Among 1026 patients in the retrospective nationwide reperfusion therapy registry, 845 (82.3%) had at least one comorbidity. As the number of comorbidities increased, the likelihood of mortality within 6 months also increased (p<0.001). Six out of the 19 comorbidities were included for developing the reperfusion comorbidity index on the basis of the odds ratios in the multivariate logistic regression analysis. This index showed good prediction of 6-month mortality in the retrospective cohort (area under the curve [AUC], 0.747; 95% CI, 0.704-0.790) and in 333 patients in the prospective cohort (AUC, 0.784; 95% CI, 0.709-0.859). Consideration of comorbidities might be helpful for the prediction of the 6-month mortality in patients with acute ischemic stroke who receive reperfusion therapy.
식별자
- Scopus EID
- 2-s2.0-85102584295
- WoS UID
- 000630511800009



로그인
연구물 목록으로